Get started
Elite Pharmaceuticals, Inc.Elite Pharmaceuticals, Inc.Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

ELTP chart


Full chart

ELTP upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪598.34 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
29.3246
Basic EPS (TTM)
0.0193 USD
Net income (FY)
‪20.11 M‬ USD
Revenue (FY)
‪56.63 M‬ USD
Shares float
‪833.24 M‬
Beta (1Y)
0.96

Employees


Employees (FY)
64
Change (1Y)
+11 +20.75%
Revenue / Employee (1Y)
‪884.77 K‬ USD
Net income / Employee (1Y)
‪314.20 K‬ USD

About Elite Pharmaceuticals, Inc.


Sector
Health Technology
CEO
Nasrat A. Hakim
Headquarters
Northvale
Website
elitepharma.com
Founded
1997
FIGI
BBG000DPZTK5
Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the Abbreviated New Drug Applications and New Drug Applications segments. The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ELTP news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ELTP is 0.5751 USD — it has increased by 2.68% in the past 24 hours. Watch Elite Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Elite Pharmaceuticals, Inc. stocks are traded under the ticker ELTP.
ELTP stock has risen by 9.75% compared to the previous week, the month change is a 33.78% rise, over the last year Elite Pharmaceuticals, Inc. has showed a 379.65% increase.
ELTP reached its all-time high on Mar 7, 2000 with the price of 24.5000 USD, and its all-time low was 0.0230 USD and was reached on Dec 6, 2021. View more price dynamics on ELTP chart.
See other stocks reaching their highest and lowest prices.
ELTP stock is 5.18% volatile and has beta coefficient of 0.96. Track Elite Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Elite Pharmaceuticals, Inc. there?
Today Elite Pharmaceuticals, Inc. has the market capitalization of ‪598.34 M‬, it has decreased by −0.06% over the last week.
Yes, you can track Elite Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Elite Pharmaceuticals, Inc. is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
ELTP net income for the last quarter is ‪615.77 K‬ USD, while the quarter before that showed ‪3.33 M‬ USD of net income which accounts for −81.49% change. Track more Elite Pharmaceuticals, Inc. financial stats to get the full picture.
No, ELTP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has 64.00 employees. See our rating of the largest employees — is Elite Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Elite Pharmaceuticals, Inc. EBITDA is ‪14.81 M‬ USD, and current EBITDA margin is 21.76%. See more stats in Elite Pharmaceuticals, Inc. financial statements.
Like other stocks, ELTP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Elite Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Elite Pharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Elite Pharmaceuticals, Inc. stock shows the buy signal. See more of Elite Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.